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Abstract
A gluten-free diet is currently the only effective means 
of treating individuals with celiac disease. Such a diet 
enables celiac patients to control their symptoms 
and avoid various complications associated with this 
condition. However, while the quality of gluten-free 
foods has significantly improved during recent decades, 
maintenance of a gluten-free diet does not necessarily 
ensure adequate nutritional intake. Because oats 
are an important source of proteins, lipids, vitamins, 
minerals, and fibre, their inclusion in a gluten-free 
diet might improve the nutritional status of a celiac 
patient. Although oats are included in the list of gluten-
free ingredients specified in European regulations, 
their safety when consumed by celiac patients remains 
debatable. Some studies claim that pure oats are 
safe for most celiac people, and contamination with 
other cereal sources is the main problem facing 
people with this disease. However, it is necessary to 
consider that oats include many varieties, containing 
various amino acid sequences and showing different 
immunoreactivities associated with toxic prolamins. 
As a result, several studies have shown that the 
immunogenicity of oats varies depending on the cultivar 
consumed. Thus, it is essential to thoroughly study 
the variety of oats used in a food ingredient before 
including it in a gluten-free diet.
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Core tip: Symptoms of celiac disease are triggered by 
an abnormal reaction to gluten, and the only treatment 
for celiac disease is the patient’s adherence to a strict 
gluten-free diet. While inclusion of oats in a gluten-free 
diet might improve its overall nutritional value, their 
use in such diets remains controversial. This review 
summarizes recent advances made in understanding 
the nutritional properties of oats and their role in celiac 
disease.
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INTRODUCTION
Celiac disease (CD) is a lifelong autoimmune disease 
characterized by an aberrant inflammatory response 
to dietary gluten in genetically susceptible individuals. 
CD is one of the most common chronic digestive 
disorders, and afflicts about 1% of the population in 
Western countries; moreover, recent studies suggest 
that its prevalence is increasing[1,2]. Certain individuals 
show a strong and complex genetic predisposition to 
this disease. Although 95% of celiac patients are HLA-
DQ2 or -DQ8 positive, the presence of these alleles 
is not strongly predictive for the disease[3,4]. In recent 
years, the clinical spectrum of CD patients has been 
expanded to include asymptomatic individuals, as 
well as individuals with minimal symptoms (the most 
difficult to detect) and extra-intestinal symptoms[5-7]. 
However, regardless of its symptomatic presentation, 
virtually all cases of active CD occur after the sus-
ceptible individual has received dietary exposure to the 
environmental antigen, gluten. In patients with CD, 
the ingestion of gluten proteins contained in wheat, 
barley, and rye results in characteristic inflammation, 
villous atrophy, and crypt hyperplasia in the upper 
small intestine[5].
During the early 1980s, the spectrum of gluten-
related disorders was relatively simple: CD and 
dermatitis herpetiformis (CD of the skin). While a 
gluten-free diet (GFD) is still recommended for all 
patients with CD, the area of CD research is changing 
rapidly, and wheat allergies, gluten ataxia, and 
nonceliac gluten sensitivity have recently been added 
as new gluten-related topics for study[8]. The only 
treatment for these disorders remains adherence to a 
GFD; however, many patients experience persistent 
CD-related symptoms despite their best efforts to 
avoid dietary gluten. A GFD is expensive and difficult 
to maintain because many products made from 
gluten-containing grains are Western dietary staples. 
Moreover, the contents of a GFD do not always ensure 
that an individual receives adequate nutrition[9,10]. In 
fact, medical problems related to inadequate nutrition 
have been described in CD patients following their long-
term treatment with a strict GFD. Such observations 
might possibly be explained by the composition and 
nutritional quality of commercially available gluten-
free products. While individuals on a GFD need to 
replace wheat, barley, rye, and their derivatives with 
foods derived from naturally gluten-free cereal grains 
(e.g., rice, corn, buckwheat, sorghum, etc.), but the 
recommended amounts of fibre, iron and calcium can 
be more difficult to obtain on such a diet and good 
planning is required[11]. Oats contain both soluble 
and insoluble dietary fibre, B-complex vitamins, iron, 
and proteins[12,13], and have recently been considered 
for inclusion in a GFD. However, while oats might 
improve the nutritional value of a GFD, their safety for 
consumption by celiac patients has been the subject of 
controversy.
NUTRITIONAL AND PHARMACOLOGICAL 
PROPERTIES OF OATS
Composition
Oat grain is characterized by its good taste and 
dietetic properties, as well as an ability to stimulate 
metabolic changes in the bodies of humans and 
animals. Furthermore, oat grain is a rich source of 
proteins with favourable amino acid contents and high 
nutritional value, and as other beneficial ingredients 
including dietary fibre, antioxidants, vitamins, phenolic 
compounds, minerals, and essential unsaturated fatty 
acids[14-16]. When compared with other cereal grains, 
oat grain contains larger amounts of total protein and 
crude fat, and a small amount of crude fibre. The 
major nutritional components of oats are shown in 
Table 1.
Health benefits
Several studies have described oats as a functional 
food with the ability to lower blood cholesterol and 
sugar levels, reduce hypertension, help control 
childhood asthma, reduce body weight, and also 
provide immunomodulatory, antioxidant, and antia-
therogenic effects[14,17-19] (Table 2). Oats also contain 
significant amounts of vitamins, minerals, fibre, 
and phytochemicals that regulate intestinal transit 
times and increase the production of butyrate and/or 
other faecal short chain fatty acids produced by gut 
microflora. As a result, the long-term dietary intake 
of oats or oat bran might benefit patients suffering 
from inflammatory bowel disease, ulcerative colitis, 
colorectal adenoma or cancer. However, further studies 
are required to accurately assess the benefits provided 
by increased oat consumption when treating bowel 
disorders[20].
Additionally, due to the well-established effect of 
oats on the risk for coronary heart disease, in 1997 
the United States Food and Drug Administration (FDA) 
approved the heart-health benefit claim shown on the 
label of many foods containing soluble fibre derived 
from oats. Moreover, in 2010, a European Food Safety 
Authority (EFSA) panel concluded that current scientific 
evidence supports the following two-part statement: 
“Oat β-glucan has been shown to lower/reduce blood 
cholesterol. Blood cholesterol lowering may reduce the 
risk of coronary heart disease”.
OATS AND CELIAC DISEASE
Oat avenins
As the prolamin components of oat seeds, the 
avenins are known to exist as both monomers and 
Table 2  Health benefits of oats
Table 1  Main nutritional components of oats
11827 November 7, 2015|Volume 21|Issue 41|WJG|www.wjgnet.com
disulfide-linked aggregates[21]. Similar to other cereal 
prolamins, the avenin polypeptides in oats tend to be 
rich in proline and glutamine, and the protein regions 
enriched in these two amino acids are associated 
with elicitation of CD. However, when compared to 
prolamins in other cereal grains, oat prolamins show 
the following differences in their molecular size, 
percentage, and amino acid content: (1) prolamins 
account for 10%-20% of the total protein in oats, 
compared to 40%-50% of the total protein in 
wheat[22,23]; (2) among the accepted prolamins, those 
found in maize, sorghum, and rice generally have the 
lowest contents of proline and glutamine (25%-30%), 
while prolamines in the Triticeae tribe (wheat, barley, 
and rye) can have proline plus glutamine contents 
that exceed 70% of their total amino acids. In 
contrast, proline and glutamine generally comprise 
35%-50% of amino acids found in the prolamins of 
oats[24]; (3) in contrast to the single longer repetitive 
domain found in Triticeae prolamins, oat avenins 
contain two shorter domains with high contents of 
proline and glutamine[24]; and (4) the disulfide pattern 
in oat prolamins is different from those reported in 
wheat γ-gliadins[25] and low molecular weight (LMW)-
glutenins[26]. In particular, the tandem cysteines at 
positions 145-146 in oat prolamins form a disulfide 
bond. This is in contrast to wheat proteins, where the 
two tandem cysteines are bonded to more distant 
cysteines within the prolamin[24].
Despite these reported differences, the avenins have 
not been well studied. As a result, the complete avenin 
genes described in current genetic databases represent 
only a few genotypes, and the variability displayed by 
avenin genes in oats is not well represented[21].
Clinical studies
The inclusion of oats in gluten-free foods is con-
troversial, as previous studies have shown contra-
dictory results regarding their toxicity. Janatuinen 
et al[27] conducted the first controlled study on the 
toxic effects of oats in CD patients, and since that 
time several other similar investigations have been 
conducted. Some researchers have claimed that 
celiac patients can consume oats and show no 
signs of intestinal inflammation[12,28-31]. In a study 
conducted by Størsrud et al[32,33], a small number of 
adult celiac subjects consumed pure oats (93 g/d) for 
2 years with no reported adverse effects. The same 
Components Properties Ref.
Proteins Albumins, globulins, prolamins, and glutenins Oats are distinct among cereals due to their higher protein 
concentration and distinct protein composition. The major storage 
proteins are globulins
[50, 51]
Carbohydrates β-glucan, glucose, fructose, pentosans, saccharose, 
kestose, neokestose, bifurcose, neobifurcose, acid 
galactoarabinoxylan, etc
β-glucan is the most important component because it is a constituent 
of the dietary fibre obtained from oats. β-glucan has important 
functional and nutritional properties, and exhibits a high viscosity at 
relatively low concentrations
[52, 53]
Lipids Oat lipids are highly unsaturated and contain 
several essential fatty acids
Oats, after corn, have the highest lipid content of any cereal. Oat lipids 
include very high levels of antioxidants
[54, 55]
Antioxidants Vitamin E (tocols), phytic acid, phenolic compounds, 
avenanthramides, flavonoids, and sterols
Antioxidants may reduce serum cholesterol concentrations, and 
inhibit the growth of certain cancer cells
[55]
Effect Findings Ref.
Hypocholesterolemic An effect derived from β-glucan content, and demonstrated in normal and hypercholesterolemic subjects. The 
statistical significance of this cholesterol reduction has been variable, and remains controversial
[15, 18]
Hypoglycaemic Studies have suggested that oat consumption can significantly decrease insulin response, fasting blood glucose 
levels, and the incidence of postprandial hyperglycaemia. However, some studies have failed to identify a diet-
related effect on glycaemic control or a person’s insulinemic response to oat-enriched products
[56-58]
Prevention of cancer Selenium, present in oats, is involved in DNA repair and associated with a reduced risk for cancer; especially 
colon cancer. Furthermore, it is found in foods with a high fibre content
[59-61]
Reduction of hypertension Soluble fibre-rich whole oats may be effective when consumed as dietary therapy for the prevention and adjunct 
treatment of hypertension
[62]
Immunomodulatory β-glucans act by stimulating the immune system and inhibiting the growth of various bacteria, viruses, fungi, 
and parasites
[63]
Antioxidant Oats contain chemicals with potential antioxidant properties; e.g., vitamin E (tocols), phytic acid, and phenolic 
compounds, etc
[55]
Antiatherogenic In vivo studies of atherosclerosis showed that oat bran reduced plasma cholesterol levels. However, it was 
difficult to determine whether its antiatherogenic effect was a result of reduced plasma cholesterol alone, or if 
additional effects of other oat components contributed to the result
[64]
Obesity control Studies revealed that oats effectively reduced obesity, as well as indexes of serum lipid levels and liver function. 
These effects were observed when using β-glucan with the proper molecular weight
[14, 52]
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researchers also conducted a study in which a group 
of celiac children ingested a median of 43 g (up to 
81 g/d) of oats daily for 2 years[34] with no adverse 
effects. Moreover, a randomized double-blind study 
conducted with newly diagnosed CD children showed 
that consumption of an oat-containing GFD for 1 
year did not interfere with their clinical, serological or 
small bowel mucosal recovery. However, despite those 
results, 26% of the children in the oat-containing 
GFD group withdrew from that study for unknown 
reasons[34,35].
While the previously mentioned studies appear 
to support the safety of oat consumption by celiac 
patients, the results of other studies suggest that 
regular consumption of certain types of oats may 
be impossible for such patients, due to their toxic 
effects. Those studies revealed that oats can trigger 
an immune reaction in celiac patients[28,36-38] that 
results in activation of mucosal T-cells, subsequent 
gut inflammation, and eventual villous atrophy[37]. In 
those patients, the immune response against avenins 
may have been triggered by a mechanism similar to 
that which triggers a response to gluten contained in 
wheat, rye, or barley. Lundin et al[36] studied 19 celiac 
patients who consumed 50 grams of oats/day for 12 
wk, and found that one patient was oat sensitive. CD 
patients have circulating anti-avenin antibodies[39,40], 
and a recent study revealed that dietary oats can alter 
the mRNA immune status of intestinal mucosa cells; 
suggesting T-cell activation and the presence of leaky 
tight-junctions[41]. Such findings indicate the need to 
distinguish between groups of celiac patients based 
on their sensitivity to different cereal grains, and also 
to identify the source of immunogenicity in avenin 
peptides.
Gluten contamination of commercial oat products
The phrase “pure oats” is used to describe oats that 
after being analysed using current test methods, 
appear to be uncontaminated with gluten from other 
closely related cereal grains, such as wheat, barley, 
and rye. However, the differences in the oat products 
used and the testing and reporting of the purity of oats 
further limited a comprehensive safety assessment. 
When studying literature reports, the study design 
or protocol did not always clearly describe the specifi-
cations used for defining “pure and uncontaminated” 
oats. While the most recent reports usually indicate 
whether the oats used in a particular study were tested 
for purity, many studies fail to indicate the lower limit 
of detection for their testing techniques or the cut-off 
values used when reporting that oat samples were free 
of gluten from other cereal grains.
According to the Codex Standard for food for 
special dietary use by persons intolerant to gluten, 




pdf), oats can be tolerated by most but not all people 
who are intolerant to gluten. Therefore, whether 
oats that are not contaminated with wheat, rye or 
barley and are contained in foods covered by this 
standard can be considered safe for consumption 
by celiac patients may eventually be determined 
at the national level. Moreover, according to Com-
mission Regulation (EC) No 41/2009 (http://eur-
lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:
L:2009:016:0003:0005:EN:PDF), which addresses 
the composition and labelling of foodstuffs suitable 
for people intolerant to gluten, the risk that oats may 
become contaminated with wheat, rye or barley during 
grain harvesting, transport, storage or processing 
remains a major concern. Therefore, the risk that 
oat-containing products might be contaminated with 
exogenous gluten should be taken into consideration 
when creating their labels.
Some studies have utilized the R5 ELISA method to 
determine the level of contamination in wheat, barley, 
or rye in oat products[42-44]. Koerner et al[43] used this 
method to confirm that the commercial oat supply in 
Canada is heavily contaminated with gluten from other 
grains. For example, about 88% of the tested oat 
samples (n = 133) showed a gluten level > 20 mg/kg. 
However, the problem with using this method is that 
the R5 antibody can react with certain types of pure 
oat seed[45]; hence, a test result suggesting “suspected 
contamination” from exogenous toxic cereal grains 
may not be real, due the R5 antibody reacting with 
certain amino acid sequences in the native oat 
proteins.
Diversity in potential immunogenicity depends on oat 
cultivars
Differences in the type of oat grain, oat purity, study 
design, as well as the specifications for gluten-free 
products in different countries, are some reasons 
why the current studies have not clearly established 
whether or not oats can be safely consumed by all 
celiac patients. These apparent contradictions might 
be explained by the fact that the oat varieties used in 
the diverse studies were different in regards to their 
prolamin genes, protein amino acid sequences, and 
the immunoreactivities of their toxic prolamins[46,47].
Our research group conducted a study using 
nine different varieties of oats obtained from various 
Australian and Spanish commercial sources, and 
demonstrated that oat immunogenicity varies de-
pending on the cultivar used[45]. The oat grains were 
carefully inspected, controlled to maintain purity, and 
shown to be free of contamination. An analysis of DNA 
amplification products confirmed that the oat samples 
were not contaminated with wheat, barley, rye, or any 
mixture of these grains. The toxicity of each oat variety 
was evaluated using a moAb G12 immunoassay. The 
antibody used in the assay was obtained from the 
Comino I et al . Oats in celiac disease
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α-2 gliadin 33-mer peptide, which is one of the most 
toxic peptides for CD patients. The nine varieties of 
oats were classified into three groups (high reactivity, 
intermediate activity, and no reactivity) based on their 
moAb G12 reactivity. We found that reactivity with 
the anti-33-mer moAb shown by the different oat 
varieties was correlated with T-cell proliferation and 
interferon gamma production by blood T-cells isolated 
from CD patients. These results suggest that a moAb 
G12-based immunotechnique may be a pragmatic 
method for evaluating the potential immunotoxicity of 
commercial cereals and grains[45,48].
Subsequent studies confirmed a direct correlation 
between the immunogenicity of the different varieties 
of oats and the presence of specific peptides with 
higher/lower potential immunotoxicity. This finding 
may explain why certain varieties of oats produce 
toxic effects when consumed by celiac patients, while 
others produce no adverse effects[21,49]. Moreover, oat 
peptides obtained from toxic cultivars have showed to 
differentially stimulate bona fide circulating dendritic 
cells obtained from celiac patients.
While inclusion of oats in a GFD might be beneficial 
due to their nutritional and health benefits, the 
source of the oats used and the cultivar selected are 
important factors to be considered. These factors 
must also be taken into account when developing food 
safety regulations, labelling oat-containing products as 
gluten-free, and designing clinical trials to study the 
effect of oats in celiac patients.
CONCLUSION
In summary, oats possess a variety of pharmacological 
activities and may exert antioxidant, anti-inflam-
matory, antidiabetic, and anticholesterolaemic effects. 
These properties have led to their wider use in human 
food. Inclusion of oats in a gluten-free diet might be 
valuable due to their nutritional and health benefits, 
and several countries currently permit oats to be 
included as an ingredient in such diets. However, it is 
extremely important to remember that in vitro studies 
have shown that the immunogenicity of oats varies 
depending on the cultivar used. Future clinical studies 
should be directed to the development of clinical 
trials with varieties previously identified as safe by 
reliable in vitro methods, such as moAb G12-based 
immunotechniques.
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